🇺🇸 FDA
Patent

US 11617800

Nanoparticle-enhanced activity of a potassium channel-blocking peptide

granted A61KA61K38/17A61K38/1767

Quick answer

US patent 11617800 (Nanoparticle-enhanced activity of a potassium channel-blocking peptide) held by The Government of the United States of America, as represented by the Secretary of the Navy expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America, as represented by the Secretary of the Navy
Grant date
Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K38/17, A61K38/1767, A61K47/52, A61K47/6923